Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

21 - 30 von 129

	21	Evaluating the Impact of Data Exclusivity on the Price of Pharmaceutical Imports Enthalten in Journal of globalization and development Bd. 14, 2023, Nr. 1: 1-20. 20 S.
	22	Comparative assessment of immunogenicity of recombinant insulin Aspart from BioGenomics and its originator NovoRapid® in adult patients with type 2 diabetes mellitus Enthalten in Journal of endocrinological investigation 26.12.2023: 1-12
	23	Effektivität und Sicherheit nach einem Switch vom Originator Infliximab auf das Biosimilar SB2 bei CED-Patienten: 24-Monatsdaten einer prospektiven Kohortenstudie Cohnen, Sarah. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2022
	24	Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator Valor-Méndez, Larissa. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2022
	25	GLODAPv2.2022: the latest version of the global interior ocean biogeochemical data product Enthalten in Earth system science data Bd. 14, 2022, Nr. 12: 5543-5572. 30 S.
	26	Effectiveness of SB4 transition from originator etanercept in rheumatoid arthritis and axial spondyloarthritis: A subgroup analysis from the BENEFIT study Enthalten in Rheumatology and immunology research Bd. 3, 2022, Nr. 1: 31-37. 7 S.
	27	Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial Rugo, Hope S.. - Freiburg : Universität, 2021
	28	Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer Rugo, Hope S.. - Freiburg : Universität, 2021
	29	Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab Fischer, Sarah Cornelia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021
	30	Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab Fischer, Sarah Cornelia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021